This study is led by Prof. Dr. Shengying Li (State Key Laboratory of Microbial Technology, Shandong University) and Ass. Prof. Dr. Biaobiao Zhang (School of Science, Westlake University). The team ...
Sagimet Biosciences cleared an IND for TVB-3567, a FASN inhibitor for acne, with Phase 1 trials planned for 2025. Sagimet Biosciences Inc. announced the clearance of its Investigational New Drug (IND) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results